Market Research Reports and Industry Reports

US Drugs of Abuse POC/Point-of-Care Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of three POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for drugs of abuse procedures
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Ambulatory Care Centers 
       
- Analysis of drugs of abuse procedures

Competitive Assessments

- Assessments of major POC suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new instruments and reagent systems with potentially
  significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearchs proprietary data files.

Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide Market and Technology Overview
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
Worldwide Business Environment
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
Table of Contents (continued)
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Drugs of Abuse Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
2. Emergency Departments
a. Market Summary
b. Drugs of Abuse Test volume and Sales Forecasts
D. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Drugs of Abuse Test Volume and Sales Forecasts
Table of Contents (continued)
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Drugs of Abuse Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
2. Emergency Departments
a. Market Summary
b. Drugs of Abuse Test volume and Sales Forecasts
D. Ambulatory Care Centers
1. Introduction
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Drugs of Abuse Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
2. Emergency Departments
a. Market Summary
b. Drugs of Abuse Test volume and Sales Forecasts
D. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Drugs of Abuse Test Volume and Sales Forecasts
Table of Contents (continued)
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges


List Of Tables

Major Companies Developing or Marketing

Drugs of Abuse Tests

 U.S.A., Physician Office/Group Practice

Laboratories Forecast by Practice Size

 U.S.A., Physician Offices/Group Practices

Forecast by Type

U.S.A., Office-Based Physicians

Forecast by Practice Type

U.S.A., Physician Offices/Group Practices

Drugs of Abuse Test Volume Forecasts

 U.S.A., Physician Offices/Group Practices

Drugs of Abuse Reagent and Instrument Sales Forecast

 U.S.A., Ancillary Hospital Locations Estimated Number

 U.S.A., Ancillary Hospital Locations Annual Utilization

U.S.A., Hospital Emergency Departments

Drugs of Abuse Test Volume Forecast

U.S.A., Hospital Emergency Departments

Drugs of Abuse Reagent and Instrument Sales Forecast

U.S.A., Ambulatory Care Centers Estimated

Number of Facilities and Patient Visits

U.S.A., Ambulatory Care Centers

Most Frequent Diagnoses

U.S.A., Ambulatory Care Centers

Drugs of Abuse Test Volume Forecast

 U.S.A., Ambulatory Care Centers

Drugs of Abuse Reagent and Instrument Sales Forecast


Brushless DC Motors Market - Global Forecasts to 2021

Brushless DC Motors Market by Type (Inner Rotor, and Outer Rotor), Speed (<500 RPM, 501 – 2000 RPM, 2001 – 10000 RPM, >10000 RPM), End User (Manufacturing, Medical Devices, Automotive,

USD 5650View Report

The YTL Communications transforms support systems to improve customer experience and cut costs

Communications is a leading provider of broadband services in Malaysia over its WiMAX network. This report assesses  Communications & apos; transformation programme that deployed an all new BSS and OSS

USD 999View Report

Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016

Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016

USD 2995View Report

2017 Vietnam Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next

USD 3750View Report

2017 Venezuela Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next

USD 3750View Report

2017 United Arab Emirates Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next

USD 3750View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 2500
  • Global Licence    $ 5500
  • DataPack    $ 1600
$ 2500

Reports Details

Published Date : Aug 2016
No. of Pages :165
Country :United States of America
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment